UFF
CRL icon

USA Financial Formulas’s Charles River Laboratories CRL Stock Holding History

USA Financial Formulas’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 375
2021
Q4 		$0 Sell
1
-2,672
-100% -$1.04M ﹤0.01% 395
2021
Q3 		$1.1M Buy
2,673
+1,526
+133% +$634K 0.99% 35
2021
Q2 		$424K Buy
1,147
+214
+23% +$71.5K 0.36% 87
2021
Q1 		$270K Buy
+933
New +$259K 0.22% 115
2020
Q4 		– Sell
-1,633
Closed -$370K – 335
2020
Q3 		$370K Buy
+1,633
New +$339K 0.28% 90
2017
Q4 		– Sell
-5,390
Closed -$582K – 276
2017
Q3 		$582K Buy
+5,390
New +$554K 0.14% 142
2015
Q2 		– Sell
-6,807
Closed -$540K – 225
2015
Q1 		$540K Buy
+6,807
New +$502K 0.18% 93

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

USA Financial Formulas's CRL Position: Q1 2022 in Review

USA Financial Formulas sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 1 share.

USA Financial Formulas first reported a position in CRL in Q1 2015 and held it in 7 quarters. The position peaked at $1.1M in Q3 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • USA Financial Formulas reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • USA Financial Formulas sold 1 Charles River Laboratories share in Q1 2022.
  • USA Financial Formulas first reported a position in Charles River Laboratories in Q1 2015 and held it in 7 quarters.
  • USA Financial Formulas's Charles River Laboratories position peaked at $1.1M in Q3 2021.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on USA Financial Formulas's 13F filing for Q1 2022, filed 16 Aug 2022.